Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial
Gravis, Gwenaelle, Dr, Fizazi, Karim, Prof, Joly, Florence, Prof, Oudard, Stéphane, Prof, Priou, Franck, MD, Esterni, Benjamin, MSc, Latorzeff, Igor, MD, Delva, Remy, MD, Krakowski, Ivan, Prof, Laguerre, Brigitte, MD, Rolland, Fréderic, MD, Théodore, Christine, MD, Deplanque, Gael, MD, Ferrero, Jean Marc, Prof, Pouessel, Damien, MD, Mourey, Loïc, MD, Beuzeboc, Philippe, MD, Zanetta, Sylvie, MD, Habibian, Muriel, Berdah, Jean François, MD, Dauba, Jerome, MD, Baciuchka, Marjorie, MD, Platini, Christian, MD, Linassier, Claude, Prof, Labourey, Jean Luc, MD, Machiels, Jean Pascal, Prof, El Kouri, Claude, MD, Ravaud, Alain, Prof, Suc, Etienne, MD, Eymard, Jean Christophe, MD, Hasbini, Ali, MD, Bousquet, Guilhem, MD, Soulie, Michel, Prof
Published in The lancet oncology (01.02.2013)
Published in The lancet oncology (01.02.2013)
Get full text
Journal Article
Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model
Gravis, Gwenaelle, Boher, Jean-Marie, Fizazi, Karim, Joly, Florence, Priou, Franck, Marino, Patricia, Latorzeff, Igor, Delva, Remy, Krakowski, Ivan, Laguerre, Brigitte, Walz, Jochen, Rolland, Fréderic, Théodore, Christine, Deplanque, Gael, Ferrero, Jean-Marc, Pouessel, Damien, Mourey, Loïc, Beuzeboc, Philippe, Zanetta, Sylvie, Habibian, Muriel, Berdah, Jean-François, Dauba, Jerome, Baciuchka, Marjorie, Platini, Christian, Linassier, Claude, Labourey, Jean-Luc, Machiels, Jean Pascal, El Kouri, Claude, Ravaud, Alain, Suc, Etienne, Eymard, Jean-Christophe, Hasbini, Ali, Bousquet, Guilhem, Soulie, Michel, Oudard, Stéphane
Published in European urology (01.08.2015)
Published in European urology (01.08.2015)
Get full text
Journal Article
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies
Lin, Chia-Chi, Garralda, Elena, Schöffski, Patrick, Hong, David S, Siu, Lillian L, Martin, Miguel, Maur, Michela, Hui, Rina, Soo, Ross A, Chiu, Joanne, Zhang, Tian, Ma, Brigette, Kyi, Chrisann, Tan, Daniel Sw, Cassier, Philippe A, Sarantopoulos, John, Weickhardt, Andrew, Carvajal, Richard D, Spratlin, Jennifer, Esaki, Taito, Rolland, Fréderic, Akerley, Wallace, Deschler-Baier, Barbara, Rispoli, Lawrence, Samant, Tanay S, Chowdhury, Niladri Roy, Gusenleitner, Daniel, Kwak, Eunice L, Askoxylakis, Vasileios, De Braud, Filippo
Published in Oncoimmunology (2024)
Published in Oncoimmunology (2024)
Get full text
Journal Article
NISCAHN: a phase II trial of nivolumab in patients with salivary gland carcinoma (Unicancer ORL-08)
Christian Borel, Caroline Even, Christophe Le Tourneau, Jerome Fayette, Laurence Bozec, Joël Guigay, Sylvie Chabaud, Laurence Digue, Lionnel Geoffrois, Fréderic Rolland, Didier Cupissol, Anne Françoise Dillies, Sylvie Zanetta, Sophie Couchon-Thaunat, Valérie Costes-Martineau, Anne Sudaka-Bahadoran, Isabelle Jallut, Florence Garic, Audrey Lardy-Cleaud
Published in BMJ Oncology (01.12.2023)
Published in BMJ Oncology (01.12.2023)
Get full text
Journal Article
Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial
Gravis, Gwenaelle, Boher, Jean-Marie, Joly, Florence, Soulié, Michel, Albiges, Laurence, Priou, Franck, Latorzeff, Igor, Delva, Remy, Krakowski, Ivan, Laguerre, Brigitte, Rolland, Frédéric, Théodore, Christine, Deplanque, Gael, Ferrero, Jean-Marc, Culine, Stéphane, Mourey, Loïc, Beuzeboc, Philippe, Habibian, Muriel, Oudard, Stéphane, Fizazi, Karim
Published in European urology (01.08.2016)
Published in European urology (01.08.2016)
Get full text
Journal Article
An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer
Powles, Thomas, Carroll, Danielle, Chowdhury, Simon, Gravis, Gwenaelle, Joly, Florence, Carles, Joan, Fléchon, Aude, Maroto, Pablo, Petrylak, Daniel, Rolland, Frédéric, Cook, Natalie, Balar, Arjun V., Sridhar, Srikala S., Galsky, Matthew D., Grivas, Petros, Ravaud, Alain, Jones, Robert, Cosaert, Jan, Hodgson, Darren, Kozarewa, Iwanka, Mather, Richard, McEwen, Robert, Mercier, Florence, Landers, Dónal
Published in Nature medicine (01.05.2021)
Published in Nature medicine (01.05.2021)
Get full text
Journal Article
Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma
Auvray, Marie, Auclin, Edouard, Barthelemy, Philippe, Bono, Petri, Kellokumpu-Lehtinen, Pirkko, Gross-Goupil, Marine, De Velasco, Guillermo, Powles, Thomas, Mouillet, Guillaume, Vano, Yann-Alexandre, Gravis, Gwenaëlle, Mourey, Loïc, Priou, Franck, Rolland, Frédéric, Escudier, Bernard, Albiges, Laurence
Published in European journal of cancer (1990) (01.02.2019)
Published in European journal of cancer (1990) (01.02.2019)
Get full text
Journal Article
Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial
ESCUDIER, Bernard, EISEN, Tim, DEMKOW, Tomasz, HUTSON, Thomas E, GORE, Martin, ANDERSON, Sibyl, HOFILENA, Gloria, MINGHUA SHAN, PENA, Carol, LATHIA, Chetan, BUKOWSKI, Ronald M, STADLER, Walter M, SZCZYLIK, Cezary, OUDARD, Stéphane, STAEHLER, Michael, NEGRIER, Sylvie, CHEVREAU, Christine, DESAI, Apurva A, ROLLAND, Frédéric
Published in Journal of clinical oncology (10.07.2009)
Published in Journal of clinical oncology (10.07.2009)
Get full text
Journal Article
Complete Remission With Tyrosine Kinase Inhibitors in Renal Cell Carcinoma
ALBIGES, Laurence, OUDARD, Stéphane, LAGUERRE, Brigitte, LEGOUFFE, Eric, KOHSER, Frédéric, DIETRICH, Pierre-Yves, THEODORE, Christine A, ESCUDIER, Bernard, NEGRIER, Sylvie, CATY, Armelle, GRAVIS, Gwenaëlle, JOLY, Florence, DUCLOS, Brigitte, GEOFFROIS, Lionel, ROLLAND, Frédéric, GUILLOT, Aline
Published in Journal of clinical oncology (10.02.2012)
Published in Journal of clinical oncology (10.02.2012)
Get full text
Journal Article
Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy
VERMORKEN, Jan B, TRIGO, José, HITT, Ricardo, KORALEWSKI, Piotr, DIAZ-RUBIO, Eduardo, ROLLAND, Frédéric, KNECHT, Rainald, AMELLAL, Nadia, SCHUELER, Armin, BASELGA, José
Published in Journal of clinical oncology (01.06.2007)
Published in Journal of clinical oncology (01.06.2007)
Get full text
Journal Article
Randomized Phase II Trial of First-Line Treatment With Sorafenib Versus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma
ESCUDIER, Bernard, SZCZYLIK, Cezary, SHAH, Sonalee, BUKOWSKI, Ronald M, HUTSON, Thomas E, DEMKOW, Tomasz, STAEHLER, Michael, ROLLAND, Frédéric, NEGRIER, Sylvie, LAFERRIERE, Nicole, SCHEURING, Urban J, CELLA, David
Published in Journal of clinical oncology (10.03.2009)
Published in Journal of clinical oncology (10.03.2009)
Get full text
Journal Article
Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study
Flippot, Ronan, Dalban, Cécile, Laguerre, Brigitte, Borchiellini, Delphine, Gravis, Gwénaelle, Négrier, Sylvie, Chevreau, Christine, Joly, Florence, Geoffrois, Lionnel, Ladoire, Sylvain, Mahammedi, Hakim, Rolland, Frédéric, Gross-Goupil, Marine, Deluche, Elise, Priou, Frank, Laramas, Mathieu, Barthélémy, Philippe, Narciso, Bérengère, Houedé, Nadine, Culine, Stéphane, Oudard, Stéphane, Chenot, Marina, Tantot, Florence, Chabaud, Sylvie, Escudier, Bernard, Albiges, Laurence
Published in Journal of clinical oncology (10.08.2019)
Published in Journal of clinical oncology (10.08.2019)
Get full text
Journal Article
Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial
Geoffrois, Lionnel, Martin, Laurent, De Raucourt, Dominique, Sun, Xu Shan, Tao, Yungan, Maingon, Philippe, Buffet, Joëlle, Pointreau, Yoann, Sire, Christian, Tuchais, Claude, Babin, Emmanuel, Coutte, Alexandre, Rolland, Frédéric, Kaminsky, Marie-Christine, Alfonsi, Marc, Lapeyre, Michel, Saliou, Marie, Lafond, Cédric, Jadaud, Eric, Gery, Bernard, Zawadi, Ayman, Tourani, Jean-Marc, Khoury, Cédric, Henry, Anne Rose, Hasbini, Ali, Guichard, François, Borel, Christian, Meert, Nicolas, Guillet, Pierre, Calais, Marie-Hélène, Garaud, Pascal, Bourhis, Jean
Published in Journal of clinical oncology (01.11.2018)
Published in Journal of clinical oncology (01.11.2018)
Get full text
Journal Article
Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial
Négrier, Sylvie, Prof, Gravis, Gwenaëlle, MD, Pérol, David, MD, Chevreau, Christine, MD, Delva, Rémy, MD, Bay, Jacques-Olivier, Prof, Blanc, Ellen, MSc, Ferlay, Céline, MSc, Geoffrois, Lionnel, MD, Rolland, Frédéric, MD, Legouffe, Eric, MD, Sevin, Emmanuel, MD, Laguerre, Brigitte, MD, Escudier, Bernard, MD
Published in The lancet oncology (01.07.2011)
Published in The lancet oncology (01.07.2011)
Get full text
Journal Article
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
Escudier, Bernard, Eisen, Tim, Stadler, Walter M, Szczylik, Cezary, Oudard, Stéphane, Siebels, Michael, Negrier, Sylvie, Chevreau, Christine, Solska, Ewa, Desai, Apurva A, Rolland, Frédéric, Demkow, Tomasz, Hutson, Thomas E, Gore, Martin, Freeman, Scott, Schwartz, Brian, Shan, Minghua, Simantov, Ronit, Bukowski, Ronald M
Published in The New England journal of medicine (11.01.2007)
Published in The New England journal of medicine (11.01.2007)
Get full text
Journal Article
Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II Study
LEFEBVRE, Jean Louis, POINTREAU, Yoann, BLOT, Emmanuel, RIVES, Michel, REYT, Emile, MARC TOURANI, Jean, GEOFFROIS, Lionel, PEYRADE, Frederic, GUICHARD, Francois, CHEVALIER, Dominique, BABIN, Emmanuel, LANG, Philippe, ROLLAND, Frederic, JANOT, Francois, CALAIS, Gilles, GARAUD, Pascal, BARDET, Etienne, ALFONSI, Marc, BAUDOUX, Alain, SIRE, Christian, DE RAUCOURT, Dominique, MALARD, Olivier, DEGARDIN, Marian, TUCHAIS, Claude
Published in Journal of clinical oncology (01.03.2013)
Published in Journal of clinical oncology (01.03.2013)
Get full text
Journal Article
Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial
Sternberg, Cora N, Dr, Skoneczna, Iwona, MD, Kerst, J Martijn, PhD, Albers, Peter, Prof, Fossa, Sophie D, Prof, Agerbaek, Mads, MD, Dumez, Herlinde, Prof, de Santis, Maria, MD, Théodore, Christine, MD, Leahy, Michael G, Chester, John D, Prof, Verbaeys, Antony, Prof, Daugaard, Gedske, Prof, Wood, Lori, MD, Witjes, J Alfred, PhD, de Wit, Ronald, Prof, Geoffrois, Lionel, MD, Sengelov, Lisa, DMSc, Thalmann, George, Prof, Charpentier, Danielle, MD, Rolland, Frédéric, MD, Mignot, Laurent, MD, Sundar, Santhanam, MRCP, Symonds, Paul, Prof, Graham, John, FRCP, Joly, Florence, Prof, Marreaud, Sandrine, MD, Collette, Laurence, PhD, Sylvester, Richard, ScD
Published in The lancet oncology (01.01.2015)
Published in The lancet oncology (01.01.2015)
Get full text
Journal Article
Axitinib in first-line for patients with metastatic papillary renal cell carcinoma: Results of the multicentre, open-label, single-arm, phase II AXIPAP trial
Negrier, Sylvie, Rioux-Leclercq, Nathalie, Ferlay, Céline, Gross-Goupil, Marine, Gravis, Gwenaëlle, Geoffrois, Lionel, Chevreau, Christine, Boyle, Helen, Rolland, Frederic, Blanc, Ellen, Ravaud, Alain, Dermeche, Slimane, Flechon, Aude, Albiges, Laurence, Pérol, David, Escudier, Bernard
Published in European journal of cancer (1990) (01.04.2020)
Published in European journal of cancer (1990) (01.04.2020)
Get full text
Journal Article
Phase I trial of copanlisib, a selective PI3K inhibitor, in combination with cetuximab in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
Marret, Grégoire, Isambert, Nicolas, Rezai, Keyvan, Gal, Jocelyn, Saada-Bouzid, Esma, Rolland, Frédéric, Chausson, Maggy, Borcoman, Edith, Alt, Marie, Klijanienko, Jerzy, Vansteene, Damien, Guigay, Joël, Kamal, Maud, Bièche, Ivan, Le Tourneau, Christophe
Published in Investigational new drugs (01.12.2021)
Published in Investigational new drugs (01.12.2021)
Get full text
Journal Article
Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial
Fizazi, Karim, Prof, Faivre, Laura, Lesaunier, François, MD, Delva, Remy, MD, Gravis, Gwenaëlle, MD, Rolland, Frédéric, MD, Priou, Frank, MD, Ferrero, Jean-Marc, Prof, Houede, Nadine, MD, Mourey, Loïc, MD, Theodore, Christine, MD, Krakowski, Ivan, MD, Berdah, Jean-François, MD, Baciuchka, Marjorie, MD, Laguerre, Brigitte, MD, Fléchon, Aude, MD, Ravaud, Alain, Prof, Cojean-Zelek, Isabelle, MD, Oudard, Stéphane, Prof, Labourey, Jean-Luc, MD, Chinet-Charrot, Paule, MD, Legouffe, Eric, MD, Lagrange, Jean-Léon, Prof, Linassier, Claude, Prof, Deplanque, Gaël, MD, Beuzeboc, Philippe, MD, Davin, Jean-Louis, MD, Martin, Anne-Laure, PharmD, Habibian, Muriel, Laplanche, Agnès, MD, Culine, Stéphane, Prof
Published in The lancet oncology (01.07.2015)
Published in The lancet oncology (01.07.2015)
Get full text
Journal Article